Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Prostanoid DP1 receptor (DP1), also known as PTGDR1, is a G protein-coupled receptor that binds prostaglandin D2 (PGD2). It is expressed in various tissues, including immune cells, cells involved in allergic/inflammatory responses, and other tissues like the gastrointestinal tract. DP1 couples primarily to Gs proteins, leading to increased cAMP levels. It plays complex roles in immune regulation, allergic disorders, pruritus, and reproduction, making it a potential therapeutic target for various diseases, but with significant safety considerations due to its context-dependent effects.
Activation of DP1 by agonists leads to Gs protein activation, increased adenylate cyclase activity, and increased intracellular cAMP levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostanoid DP1 receptor (DP1).